Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumorsA H Djeha, T A Thomson, H Leung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetinP J Mulholland, D R Ferry, D Anderson, et al.
Hematological Oncology|January 1, 1990
The myelotoxicity of carboplatin is influenced by the time of its administrationD J Kerr, C Lewis, B O'Neil, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesD Cunningham, C J Bradley, G J Forrest, et al.
Cancer Research|February 1, 1993
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusionD Bissett, A Setanoians, J Cassidy, et al.
Digestion|January 1, 1997
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancerJ P Neoptolemos, D J Kerr, H Beger, et al.
British Journal of Cancer|October 1, 1994
Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinomaC S McArdle, D J Kerr, P O'Gorman, et al.
British Journal of Cancer|April 1, 1992
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials CommitteeS B Kaye, M Brampton, P Harper, et al.
International Journal of Oncology|June 4, 1998
A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinomaL W Seymour, S P Olliff, C J Poole, et al.
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumorsA H Djeha, T A Thomson, H Leung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetinP J Mulholland, D R Ferry, D Anderson, et al.
Hematological Oncology|January 1, 1990
The myelotoxicity of carboplatin is influenced by the time of its administrationD J Kerr, C Lewis, B O'Neil, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesD Cunningham, C J Bradley, G J Forrest, et al.
Cancer Research|February 1, 1993
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusionD Bissett, A Setanoians, J Cassidy, et al.
Digestion|January 1, 1997
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancerJ P Neoptolemos, D J Kerr, H Beger, et al.
British Journal of Cancer|October 1, 1994
Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinomaC S McArdle, D J Kerr, P O'Gorman, et al.
British Journal of Cancer|April 1, 1992
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials CommitteeS B Kaye, M Brampton, P Harper, et al.
International Journal of Oncology|June 4, 1998
A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinomaL W Seymour, S P Olliff, C J Poole, et al.
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
Pageof 23